FIELD: medicine.
SUBSTANCE: invention refers to using n-thyrozol as an endothelium protective agent.
EFFECT: invention enables extending the range of agents possessing endothelium protective action.
2 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
ANTI-ISCHEMIC DRUG | 2012 |
|
RU2499593C1 |
MEANS IMPROVING MICROVASCULARIZATION IN BRAIN TISSUE | 2017 |
|
RU2650624C1 |
ANTIISHEMIC AGENT | 2008 |
|
RU2384327C1 |
AGENT RELIEVING POSTINFARCTION MYOCARDIAL REMODELING | 2020 |
|
RU2740895C1 |
USING SECOISOLARICIRESINOL AS HAEMORHEOLOGICAL, ANTI-PLATELET AND ENDOTHELIUM-PROTECTIVE AGENT | 2013 |
|
RU2532356C1 |
AGENT STIMULATING NEUROGENESIS IN ISCHEMIC CEREBRAL INJURIES | 2015 |
|
RU2585094C1 |
AGENT SHOWING ENDOTHELIUM-PROTECTIVE ACTIVITY | 2011 |
|
RU2455018C1 |
AGENT POSSESSING NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2701739C1 |
MEDICATION FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2014 |
|
RU2555335C9 |
NEUROPROTECTOR | 2009 |
|
RU2406488C1 |
Authors
Dates
2015-09-20—Published
2014-08-06—Filed